You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

LIPOSYN III 30% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Liposyn Iii 30%, and when can generic versions of Liposyn Iii 30% launch?

Liposyn Iii 30% is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in LIPOSYN III 30% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.

Drug patent expirations by year for LIPOSYN III 30%
Recent Clinical Trials for LIPOSYN III 30%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Pennington Biomedical Research CenterEarly Phase 1
The Cleveland ClinicEarly Phase 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)N/A

See all LIPOSYN III 30% clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for LIPOSYN III 30%

US Patents and Regulatory Information for LIPOSYN III 30%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira LIPOSYN III 30% soybean oil INJECTABLE;INJECTION 020181-001 Jan 13, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for LIPOSYN III 30%

When does loss-of-exclusivity occur for LIPOSYN III 30%?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 0632
Estimated Expiration: ⤷  Try a Trial

Australia

Patent: 13247058
Estimated Expiration: ⤷  Try a Trial

Brazil

Patent: 2014025232
Estimated Expiration: ⤷  Try a Trial

China

Patent: 4220113
Estimated Expiration: ⤷  Try a Trial

Denmark

Patent: 36259
Estimated Expiration: ⤷  Try a Trial

European Patent Office

Patent: 36259
Estimated Expiration: ⤷  Try a Trial

Hong Kong

Patent: 01769
Estimated Expiration: ⤷  Try a Trial

Hungary

Patent: 28339
Estimated Expiration: ⤷  Try a Trial

Israel

Patent: 4450
Estimated Expiration: ⤷  Try a Trial

Japan

Patent: 73462
Estimated Expiration: ⤷  Try a Trial

Patent: 15516201
Estimated Expiration: ⤷  Try a Trial

Mexico

Patent: 1343
Estimated Expiration: ⤷  Try a Trial

Patent: 14012226
Estimated Expiration: ⤷  Try a Trial

Poland

Patent: 36259
Estimated Expiration: ⤷  Try a Trial

Russian Federation

Patent: 30597
Estimated Expiration: ⤷  Try a Trial

Patent: 14144631
Estimated Expiration: ⤷  Try a Trial

South Korea

Patent: 2124661
Estimated Expiration: ⤷  Try a Trial

Patent: 150003199
Estimated Expiration: ⤷  Try a Trial

Spain

Patent: 88510
Estimated Expiration: ⤷  Try a Trial

Taiwan

Patent: 68466
Estimated Expiration: ⤷  Try a Trial

Patent: 1402163
Estimated Expiration: ⤷  Try a Trial

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering LIPOSYN III 30% around the world.

Country Patent Number Title Estimated Expiration
Poland 2836259 ⤷  Try a Trial
Taiwan 201402163 Cartridge holder and pen-type injector ⤷  Try a Trial
Russian Federation 2014144631 ДЕРЖАТЕЛЬ КАРТРИДЖА И ШПРИЦ-РУЧКА ⤷  Try a Trial
Australia 2013247058 Cartridge holder and pen-type injector ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.